Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Cetirizine Dry Syrup in Children with Perennial Allergic Rhinitis
NCT00257595Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cetirizine in perennial allergic rhinitis (PAR), sponsored by GSK. Started Aug 2005; status: completed.
02
Drugs
cetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00257595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257595.